Descrption:
POINT ROBERTS, WA, Delta B.C., April 03, 2006 - www.China-AsiaStocks.com (CAS) and www.BiotechIndustryStocks.com (BIS) , investor and industry news portals for the China-Asia and biotechnology sectors, feature “Global Demand Boosts Avian Flu Vaccine Market", for investors and industry following developments in the vaccine market. Biotech and Healthcare companies: Bridgetech Holdings International Inc., Generex Biotech, AVI Biopharma Inc., Hemispherx Biopharma, Inc, Carrington Laboratories and Aethlon Medical, discuss unique approaches to this potential global dilemma and offer insight to possible solutions.
To Read “Global Demand Boosts Avian Flu Vaccine Market” In Full Click Here: http://www.China-AsiaStocks.com/Articles/Avian_Flu.asp
About our CAS and BIS Portals:
www.China-AsiaStocks.com and www.BiotechIndustryStocks.com portals within the InvestorIdeas.com content umbrella, offer investors research, news and links to public companies within the China-Asia and Biotechnology sectors. CAS and BIS do not make recommendations, but offer unique free information portals to research news, articles, interviews and a growing list of participating public companies in the China-Asia and biotech industry.
Featured Sponsor Participating in the China Asia Market: (CAS is compensated by Bridgetech Holding International as disclosed in disclaimer.)
Bridgetech Holdings International Inc (OTC.PK: BGTH) For more info: http://www.china-asiastocks.com/CO/BGTH/Default.asp or visit the company's website at www.bthi.com.
Investorideas.com Disclaimer: www.InvestorIdeas.com/About/Disclaimer.asp
For More Information Contact:
Dawn Van Zant 800-665-0411
Fei Wang 866-948-0848
Email: dvanzant@investorideas.com or fwang@investorideas.com
Web Site: www.InvestorIdeas.com
Source: China-AsiaStocks.com, Bridgetech Holdings International, Generex Biotech, AVI Biopharma Inc., Hemispherx, Carrington Laboratories and Aethlon Medical |